Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-24-055908
Filing Date
2024-03-01
Accepted
2024-03-01 16:08:17
Documents
9
Effectiveness Date
2024-03-01

Document Format Files

Seq Description Document Type Size
1 S-3ASR d827557ds3asr.htm S-3ASR 284188
2 EX-4.3 d827557dex43.htm EX-4.3 295200
3 EX-5.1 d827557dex51.htm EX-5.1 24242
4 EX-23.1 d827557dex231.htm EX-23.1 1796
5 EX-FILING FEES d827557dexfilingfees.htm EX-FILING FEES 35361
6 GRAPHIC g827557g0228013742457.jpg GRAPHIC 3266
7 GRAPHIC g827557g0228013742546.jpg GRAPHIC 1416
8 GRAPHIC g827557g43h62.jpg GRAPHIC 225500
9 GRAPHIC g827557g66h62.jpg GRAPHIC 70991
  Complete submission text file 0001193125-24-055908.txt   1050218
Mailing Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Filer) CIK: 0001770121 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-277584 | Film No.: 24709696
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)